DENVER, July 28 /PRNewswire/ -- The Colorado BioScience Association (CBSA) and the Colorado Office of Economic Development and International Trade (OEDIT) jointly announce participation of the following Colorado bioscience CEOs in the BioWest Investor Forum on August 24, 2006 (3:45 - 5:45 p.m.), at the Colorado Convention Center: Paul Berns, Allos Therapeutics; John Serino, Encision; Bill Freytag, Myogen; Patrick Mahaffy, Pharmion; and Ken Collins, Replidyne.
"This is the first time that a group of CEOs at this level have presented in one place at one event in Colorado," says Denise Brown, CBSA Executive Director, "They will discuss their newest clinical findings, regulatory approvals and other relevant investor information."
Conference registration is required in order to attend the Investor Forum. Registration details for BioWest 2006 are available at http://www.BioWestConference.com
"The success and growth in scope and attendance of the annual BioWest conference is a direct reflection of the vibrancy of the bioscience industry in Colorado," commented Freytag of Myogen. "The access to leading research science in our local academic institutions and the talented, highly educated workforce make Colorado an ideal location to grow a bioscience company."
More than 750 participants are expected at this year's BioWest. America's "Cowboy Poet" Baxter Black and NPR Science Friday(R) host Ira Flatow are the headliners for the event, along with the presentation, "Where Innovation Happens" from Federal Reserve Executive Michael Orlando.
About the Colorado Office of Economic Development and International Trade
OEDIT works with companies starting, expanding, or relocating in Colorado. The office offers a wide range of services to assist new and existing business of every size. Visit http://www.AdvanceColorado.com
About Colorado BioScience Association
CBSA is a not-for-profit corporation providing services and support for Colorado's growing biosciences industry. With more than 300 members, CBSA actively works to promote the growth of the industry by working for a better business environment, growing the state's biotech workforce, fighting for policies that support a strong bioscience industry in the state and speaking with a single voice on behalf of the industry. Visit http://www.CoBioScience.com
Contacts:
Christine Shapard, Director of Bioscience and Emerging Industries, Colorado Office of Economic Development and International Trade http://www.AdvanceColorado.com -- 303.892.3840, Christine.shapard@state.co.us
Maggie Chamberlin Holben, APR, Absolutely Public Relations http://www.absolutelypr.com -- 303.984.9801, maggie@absolutelypr.com
Colorado BioScience AssociationCONTACT: Maggie Chamberlin Holben, APR, of Absolutely Public Relations,+1-303-984-9801, maggie@absolutelypr.com, for Colorado BioScienceAssociation; or Christine Shapard, Director of Bioscience and EmergingIndustries of Colorado Office of Economic Development and InternationalTrade, +1-303-892-3840, Christine.shapard@state.co.us
